Comments

MoonLake Stock Price, Quotes and Forecasts

Q: What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MLTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$42.90

-1.31-2.96%

At close: -

$42.90

0.000.00%

After Hours: 4:00 PM EDT

MoonLake (MLTX) Forecast

News Earnings MoonLake (MLTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

MoonLake Stock Price, Quotes and Forecasts | NASDAQ:MLTX | Benzinga

Explore MoonLake stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MLTX.

Open	$44.85
Close	$42.90
Volume / Avg.	275.06K / 536.38K
Day Range	$42.85 - $44.94
52 Wk Range	31.42 - 58.26
Market Cap	$2.72B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	22.32%
Days to Cover	29.01

Recent News

Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE-689 trial.

Vandana Singh

Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta

Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week plus bankruptcy updates.

Anthony Noto

Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$44.85
Close	$42.90
Volume / Avg.	275.06K / 536.38K
Day Range	$42.85 - $44.94
52 Wk Range	31.42 - 58.26
Market Cap	$2.72B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	22.32%
Days to Cover	29.01

About MoonLake Immunotherapeutics

Sector

Health Care

Industry

Biotechnology

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MoonLake (MLTX) stock?

You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.

View our list of the best stock brokerages

Who are MoonLake (MLTX) competitors?

Other companies in MoonLake’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT), Ascentage Pharma Group (NASDAQ:AAPG) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the forecast, or price target, for MoonLake (MLTX) stock?

MoonLake has a consensus price target of $65.47.

What is the current price for MoonLake (MLTX)?

The stock price for MoonLake (NASDAQ: MLTX) is $42.9 last updated June 16, 2025 at 4:00 PM EDT.

Does MoonLake (MLTX) pay a dividend?

There are no upcoming dividends for MoonLake.

When is MoonLake (NASDAQ:MLTX) reporting earnings?

MoonLake’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is MoonLake (MLTX) going to split?

There is no upcoming split for MoonLake.

What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.